Uncategorised - European Medical Journal

ESMO Breast Cancer 2025: Gut Microbiome Linked to Breast Cancer Recurrence

New research presented at ESMO Breast 2025 reveals that certain gut bacteria and microbial functions are more common in breast cancer patients who later experience recurrence, highlighting the potential of the gut microbiome as a biomarker for relapse risk.

Phase III Trial Results: Nerandomilast in Pulmonary Fibrosis

In a Phase III clinical trial, nerandomilast, an oral phosphodiesterase 4B inhibitor, was associated with a smaller decline in lung function over 52 weeks in patients with progressive pulmonary fibrosis, when compared with placebo.

ESMO Breast Cancer 2025: Alcohol Increases Breast Cancer Risk but Not Prognosis

New research presented at ESMO Breast 2025 shows that alcohol consumption raises the risk of developing breast cancer, particularly hormone receptor-positive types, but does not appear to worsen survival or recurrence in those already diagnosed.

ESMO Breast Cancer 2025: DNA Repair Mutations May Reduce Therapy Response

New data from ESMO Breast 2025 indicate that inherited DNA repair mutations could affect the effectiveness of CDK4/6 inhibitors in treating advanced breast cancer, with mutation carriers showing lower response rates and shorter survival trends.

Invasive Candidiasis Management Gaps in ICUs Shared in 2024 Survey

Invasive candidiasis remains a significant challenge for intensive care units worldwide due to its high mortality rate, diagnostic complexity, and increasing resistance.

Seasonal Allergy Symptoms Improved With New Biologic Treatment

The PHECDA trial evaluated stapokibart as an add-on therapy during pollen season in adults with moderate-to-severe seasonal allergic rhinitis.

EuroPCR 2025: 10-year Results of the DANAMI-3-PRIMULTI Trial

Ten-year data show complete revascularisation reduces repeat procedures in STEMI patients with multivessel disease.

Osteoarthritis Surgery Reviewed: Risks, Results, and Recommendations

Surgical intervention for severe osteoarthritis continues to be a critical decision point in orthopedics.

Sexual Behavior Strongest Driver of Gut Microbiome in HIV

In a new study that challenges conventional assumptions about gut health in people living with HIV, researchers have found that sexual behavior has a stronger association with gut microbiome composition than either antiretroviral therapy (ART) regimens or weight changes.

Breaking the silence: the patient-doctor perspective on new understanding and communication in COPD management